glutamic acid has been researched along with Carcinoma, Non-Small Cell Lung in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Akingbemi, WO; Bachrach, B; Bui, AAT; Carroll, J; Cummings, AL; Dubinett, SM; Elashoff, D; Fares, CM; Garon, EB; Goldman, JW; Grogan, T; Gukasyan, J; Hornstein, N; Li, D; Lisberg, A; Lu, HY; Noor, Z; Ribas, A; Rossetti, M; Sunga, G; Zaretsky, J | 1 |
| He, P; Hou, Y; Li, N; Liu, Z; Yang, Y; Zhang, X | 1 |
| Cheng, L; Li, J; Liu, K; Long, J; Long, T; Shen, Y; Wang, Y; Yin, T | 1 |
| DI, LQ; Huang, X; Lu, YY; Luo, ZC; Qi, MY; Shan, JJ; Zhang, W | 1 |
| Hong, D; Hong, KM; Kang, JH; Kim, SY; Lee, JS; Lee, SH; Son, J; Song, J | 1 |
| Ambrosius, W; Gazdulska, J; Gołda-Gocka, I; Kozubski, W; Michalak, S; Ramlau, R; Rybacka-Mossakowska, J | 1 |
| Cui, M; Fu, L; Li, M; Mi, J; Wang, Y; Xu, Y | 1 |
| Fukuhara, T; Inoue, A; Kimura, Y; Maemondo, M; Morikawa, N; Nukiwa, T; Saijo, Y; Suzuki, T; Watanabe, H | 1 |
| Jeong, EG; Kim, MS; Lee, SH; Yoo, NJ | 1 |
1 trial(s) available for glutamic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.
Topics: Adult; Aged; Aged, 80 and over; Alanine; Antineoplastic Agents; Arginine; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; ErbB Receptors; Feasibility Studies; Female; Gefitinib; Glutamic Acid; Humans; Leucine; Lung Neoplasms; Male; Middle Aged; Mutation; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Quinazolines; Treatment Outcome | 2006 |
8 other study(ies) available for glutamic acid and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.
Topics: Carcinoma, Non-Small-Cell Lung; Glutamic Acid; HLA-B Antigens; HLA-B44 Antigen; Humans; Immunotherapy; Lung Neoplasms; Melanoma; Mutation | 2020 |
Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G2 Phase Cell Cycle Checkpoints; Glutamic Acid; Glutamine; Humans; Ketones; Lung Neoplasms; Mice; Mitochondria; NAD | 2022 |
Changes in serum amino acid levels in non-small cell lung cancer: a case-control study in Chinese population.
Topics: Adenocarcinoma; Amino Acids; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Case-Control Studies; Chromatography, Liquid; East Asian People; Glutamic Acid; Humans; Lung Neoplasms; Tandem Mass Spectrometry; Trypsin | 2022 |
[Mechanism of Cordyceps militaris against non-small cell lung cancer: based on serum metabolomics].
Topics: Alanine; Animals; Arginine; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cordyceps; Glutamic Acid; Glutamine; Glyoxylates; Humans; Lung Neoplasms; Metabolomics; Mice; Mice, Nude; Nitrogen; Phenylalanine; RNA, Transfer; Tryptophan; Tyrosine | 2022 |
Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC.
Topics: A549 Cells; Adenosine Triphosphate; Animals; Aspartic Acid; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Death; Cell Proliferation; Cell Survival; Cytosol; Drug Synergism; Fluorouracil; Gene Knockdown Techniques; Glutamic Acid; Glutaminase; Glutamine; Lung Neoplasms; Malates; Mice, Inbred BALB C; Mice, Nude; Molecular Targeted Therapy; NAD; Oxidation-Reduction; Sulfides; Thiadiazoles; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2016 |
The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients.
Topics: Aged; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cognitive Dysfunction; Female; Glutamate Decarboxylase; Glutamate Dehydrogenase; Glutamic Acid; Glutaminase; Humans; Lung Neoplasms; Male; Middle Aged; Monocytes | 2016 |
Amino acid transporter SLC38A3 promotes metastasis of non-small cell lung cancer cells by activating PDK1.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Carcinoma, Non-Small-Cell Lung; Cell Movement; Enzyme Activation; Epithelial-Mesenchymal Transition; Glutamic Acid; Histidine; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Sodium-Calcium Exchanger; Transfection | 2017 |
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias.
Topics: Acute Disease; Adenocarcinoma; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; DNA Mutational Analysis; Female; Glutamic Acid; Humans; Leukemia; Liver Neoplasms; Lung Neoplasms; Lysine; Male; Middle Aged; Mutation; Neoplasms; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins c-akt; Stomach Neoplasms | 2008 |